Growth Metrics

Envoy Medical (COCH) Return on Equity (2022 - 2025)

Envoy Medical's Return on Equity history spans 4 years, with the latest figure at 2.41% for Q4 2025.

  • Quarterly results put Return on Equity at 2.41% for Q4 2025, up 133.0% from a year ago — trailing twelve months through Dec 2025 was 2.41% (up 133.0% YoY), and the annual figure for FY2025 was 1.54%, down 41.0%.
  • Return on Equity for Q4 2025 was 2.41% at Envoy Medical, up from 1.19% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 3.51% in Q1 2024 to a low of 7.0% in Q4 2023.
  • The 4-year median for Return on Equity is 0.96% (2025), against an average of 0.45%.
  • The sharpest move saw Return on Equity plummeted -637bps in 2023, then skyrocketed 807bps in 2024.
  • Year by year, Return on Equity stood at 0.62% in 2022, then crashed by -1023bps to 7.0% in 2023, then surged by 115bps to 1.07% in 2024, then skyrocketed by 124bps to 2.41% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 2.41%, 1.19%, and 0.79% for Q4 2025, Q3 2025, and Q2 2025 respectively.